SetPoint Launches IDE Trial Of Vagus Nerve Stimulation To Treat Arthritis

 
• By Reed Miller

The randomized trial will evaluate SetPoint's bioelectronic platform in patients with moderate-to-severe rheumatoid arthritis, supported by funds secured in a recent preferred stock financing.

film x-ray both human's hands and arthritis at multiple joint

More from Clinical Trials

More from R&D